Cancer News and Research

Latest Cancer News and Research

Occupational exposures in farming and industry may be linked to death from autoimmune disease

A new study examined the possible associations between occupation and the risk of dying from systemic autoimmune diseases and found that occupational exposures in farming and industry may be linked to higher death rates from these diseases.

29 Sep 2007

Potential new therapy for uveitis

An inflammatory eye condition that is one of the world's leading causes of blindness could be treated much more effectively and easily thanks to a new discovery here.

29 Sep 2007

Meditation for rheumatoid arthritis

A revered contemplative practice for centuries, meditation has recently inspired research into its therapeutic value for everything from anxiety disorders to heart attack prevention.

29 Sep 2007

New molecular evidence of the role of the hormone prolactin in breast cancer

They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new “signaling pathway” that may regulate the growth and survival of breast cancer cells.

29 Sep 2007

Genomic profiling of lung tumors helps doctors choose most effective treatment

Determining the genetic profile of a particular lung tumor can help clinicians make the crucial decision about which chemotherapy treatment to try first.

29 Sep 2007

FDA approves new adjustable gastric band for morbid obesity

Ethicon Endo-Surgery, Inc. has announced the U.S. Food and Drug Administration (FDA) approved for marketing the REALIZE Adjustable Gastric Band, a surgical implant for weight reduction and improvement in obesity-related health conditions, such as type-2 diabetes, in individuals suffering from morbid obesity.

29 Sep 2007

Health care interventions that tackle health disparities

Studies show that minority patients generally receive a lower quality of health care compared to white patients.

29 Sep 2007

Effects of good and bad carbohydrates

The latest common wisdom on carbohydrates claims that eating so-called "bad" carbohydrates will make you fat, but University of Virginia professor Glenn Gaesser says, "that's just nonsense."

29 Sep 2007

Wine, beer and spirits all equal when it comes to breast cancer

Barcelona, Spain: One of the largest individual studies of the effects of alcohol on the risk of breast cancer has concluded that it makes no difference whether a woman drinks wine, beer or spirits (liquor) – it is the alcohol itself (ethyl alcohol) and the quantity consumed that is likely to trigger the onset of cancer.

27 Sep 2007

Pregnancy does not harm chances of survival from cancer

New research offers reassurance to women worried about whether getting pregnant after cancer treatment might worsen their prognosis.

27 Sep 2007

Exercise might actually increase the risk of developing ovarian cancer

Barcelona, Spain: A new study adds fuel to the debate over whether being fat or inactive affects the risk of developing ovarian cancer.

27 Sep 2007

Experimental drug pertuzumab boosts survival in recurrent ovarian cancer

New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.

27 Sep 2007

Over use of multivitamins may raise prostate cancer risk

About a third of American adults take some type of multivitamin on a regular basis.

27 Sep 2007

DNA damage response confers a barrier for viral tumorigenesis

Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma (KS).

27 Sep 2007

Clinical Trials Directive likely to turn Europe into the poor relation of clinical academic medicine

The Clinical Trials Directive, which came into force in May 2004 in order to create a harmonised framework for clinical drug research across Europe, is still hampering such research, according to new findings presented at the European Cancer Conference (ECCO 14).

27 Sep 2007

Chemotherapy drug gemcitabine delays progression of operable pancreatic cancer

Barcelona, Spain: Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists.

27 Sep 2007

Tumor cell receptor provides new therapeutic target

Working with a line of highly metastatic head and neck cancer cells, a research team at the Winship Cancer Institute and Emory University School of Medicine has found that a specific cell surface receptor present at very low levels in non-metastatic head and neck cancer cells.

27 Sep 2007